首页> 美国卫生研究院文献>other >Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens but protect the indigenous microbiota
【2h】

Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens but protect the indigenous microbiota

机译:修订造血干细胞移植中的抗微生物疗法:靶向病原体但保护本土微生物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Host microbiota plays important roles in providing colonization resistance to pathogens and instructing development and function of the immune system. Antibiotic treatments intended to target pathogens further weaken the host defenses and may paradoxically increase the risk of systemic infections. This consequence is especially problematic in patients undergoing hematopoietic stem cell transplantation, where the mucosal defenses are already weakened by the conditioning regimens. This review discusses the roles that indigenous microbiota plays in protecting the host and maintaining immune homeostasis. In addition, we highlight possible strategies that are being developed to allow targeted antimicrobial therapy against pathogens, while minimizing the harm to indigenous microbiota.
机译:宿主菌群在提供对病原体的定植抗性以及指导免疫系统的发育和功能方面起着重要作用。旨在针对病原体的抗生素治疗进一步削弱了宿主的防御能力,可能反而增加了全身感染的风险。在进行造血干细胞移植的患者中,这种后果尤其成问题,在这些患者中,调理方案已经削弱了粘膜的防御能力。这篇综述讨论了土著微生物群在保护宿主和维持免疫稳态方面的作用。此外,我们重点介绍了正在开发的可能策略,以针对病原体进行针对性的抗菌治疗,同时最大程度地减少对本地微生物的危害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号